Key Events This Week
1 June: Flat quarterly results reported with margin contraction and interest cost rise
1 June: Valuation metrics shift to attractive despite price decline
5 June: Week closes at Rs.128.00, down 10.46%
Aug 11, 04:01 PM
BSE+NSE Vol: 2.93 k
The next results date for Parnax Lab Ltd is scheduled for 14 August 2026....
Read full news article
Parnax Lab Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 20 July 2026. However, the analysis and financial metrics presented here reflect the stock’s current position as of 01 August 2026, providing investors with the most recent and relevant data to assess the company’s outlook.
Read full news article
Parnax Lab Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 20 Jul 2026. This revision follows a detailed reassessment of the company’s quality, valuation, financial trends, and technical indicators, reflecting a cautious stance despite some positive long-term returns.
Read full news article
Parnax Lab Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a notable improvement in its technical outlook and valuation metrics despite flat recent financial performance. The upgrade, effective from 13 July 2026, is driven by a combination of bullish technical indicators, attractive valuation relative to peers, stable financial trends, and a consistent return profile that outpaces broader market benchmarks.
Read full news article
Parnax Lab Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 8 July 2026. This change reflects a combination of flat recent financial performance, mixed technical indicators, and valuation considerations that collectively weigh on the stock’s near-term outlook despite its strong long-term returns.
Read full news article
Parnax Lab Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Sell to Hold as of 3 July 2026. This change reflects a nuanced improvement across technical indicators, valuation metrics, and financial trends, despite some recent flat quarterly performance. The stock’s recent market-beating returns and enhanced technical outlook have contributed to this reassessment.
Read full news article
Parnax Lab Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 29 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 25 June 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read full news article
1 June: Flat quarterly results reported with margin contraction and interest cost rise
1 June: Valuation metrics shift to attractive despite price decline
5 June: Week closes at Rs.128.00, down 10.46%

Parnax Lab Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 29 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 14 June 2026, providing investors with the latest insights into the company’s performance and outlook.
Read full news articleParnax Lab Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 inter alia to consider and approve Standalone and Consolidated Un-audited IND- AS Compliant Financial Results along with Limited Review Report for the quarter (Q1) and Year ended 30th June 2026 pursuant to Regulation 33 of Listing Obligation and Disclosure Requirement 2015.
The Exchange has received the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Mihir Shah
The Exchange has received the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Prakash Shah
14 Aug 2026
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available